From efficacy to effectiveness: Facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City

AIDS Patient Care and STDs

Volumn 27, Issue 4, 2013, Pages 248-254

  Golub, Sarit A ^a,b   Gamarel, Kristi E ^a,b   Rendina, H Jonathon ^b   Surace, Anthony ^a   Lelutiu Weinberger, Corina L ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; HEALTH SURVEY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MALE TO FEMALE TRANSSEXUAL; MOTIVATION; PATIENT COMPLIANCE; PRE EXPOSURE PROPHYLAXIS; PROPHYLAXIS; SEXUAL BEHAVIOR; SEXUAL HEALTH; UNITED STATES;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MOTIVATION; NEW YORK CITY; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS; SOCIOECONOMIC FACTORS; TRANSGENDERED PERSONS; YOUNG ADULT;

EID: 84876114463     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2012.0419     Document Type: Article

References (36)

1. Grant RM, Lama JR, Anderson PL,McMahan V, Liu AY, et al. Preexposure chemoprophylaxis for HIV prevention inmenwho have sex with men. New Eng J Med 2010;363:2587-2599.
2. Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New Eng J Med 2012;367:399-410.
3. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New Eng J Med 2012;367:423-434.
4. Saberi P, Gamarel KE, Neilands TB, et al. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: A mixed methods study. PLoS One 2012;7:e50061.
5. Krakower DS, Mimiaga MJ, Rosenberger JG, et al. Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an Internet social networking site. PloS One 2012;7:e33119.
6. Brooks RA, Kaplan RL, Lieber E, Landovitz RJ, Lee SJ, Leibowitz AA. Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships. AIDS Care 23:1136-1145.
7. Liu AY, Kittredge PV, Vittinghoff E, et al. Limited knowledge and use of HIV post-and pre-exposure prophylaxis among gay and bisexual men. J Acq Immune Def Syndrome 2008;47:241-247. (Pubitemid 351172193)
8. Nodin N, Carballo-Dieguez A, Ventuneac AM, et al. Knowledge and acceptability of alternative HIV prevention bio-medical products among MSM who bareback. AIDS Care 2008;20:106-115. (Pubitemid 351264545)
9. Calderon Y, Leider J, Cowan E, Brusalis C, Mantell J, Sandfort T. HIV pre-exposure prophylaxis (PrEP)-knowledge and attitudes among a New York City emergency department patient population. Retrovirology 2012;9:P94.
10. Golub SA, Kowalczyk W, Weinberger CL, Parsons JT. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acq Immune Def Syndromes 2010;54:548.
11. Khawcharoenporn T, Kendrick S, Smith K. HIV risk perception and preexposure prophylaxis interest among a hetersexual population visiting a sexual transmitted infection clinic. AIDS Patient Care STDs. 2012;26:222-223.
12. Brooks RA, Landovitz RJ, Kaplan RL, Lee S, Barkley TW. Sexual risk behavior and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: A mixed methods study. AIDS Patient Care STDs. 2012;26:87-94.
13. Anderson PL, Lama JR, Buchbinder S, et al. Expanded casecontrol analysis of drug detection in the global iPrEx trial. Sixth IAS Conference; 2011; Rome.
14. Cohen MS, Muessig KE, Smith MK, Powers KA, Kashuba ADM. Antiviral agents and HIV prevention: Controversies, conflicts, and consensus. AIDS 2012;26:1585-1598.
15. Baeten J, Celum C. Oral antiretroviral chemoprophylaxis: Current status. Curr Opin HIV/AIDS 2012;7:514-519.
16. Millett GA, Peterson JL, Flores SA, et al. Comparsisons of disparites and risks of HIV infection in black and other men who have sex with men in Canada, UK, and USA: A metaanalysis. Lancet 2012;380:341-348.
17. Cohen J. AIDS research. Microbicide fails to protect against HIV. Science 2008;319:1026-1027.
18. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. New Eng J Med 2008;359:1560-1571. (Pubitemid 351519816)
19. Okwundu C, Okoromah C. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev 2009;1.
20. Peterson L, Taylor D, Roddy R, et al. Tenofovir disoproxil fumarate for prevention of HIV infection in women: A phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials 2007;2:e27.
21. Guest G, Shattuck D, Johnson L, et al. Acceptability of PrEP for HIV prevention among women at high risk for HIV. J Women's Health 2010;19:791-798.
22. Ware NC, Wyatt MA, Haberer JE, et al. What's love got to do with it? Explaining adherence to oral antiretroviral preexposure prophylaxis for HIV-serodiscordant couples. J Acq Immune Def Syndromes. 2012;59:463.
23. Amico K, McMahan V, Goicochea P, et al. Supporting study product use and accuracy in self-report in the iPrEx study: Next step counseling and neutral assessment. AIDS Behav 2012:1-17.
24. Cooper RD, Wiebe N, Smith N, Keiser P, Naicker S, Tonelli M. Systematic review and meta-analysis: Renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis 2010;51:496-505.
25. Arnold EA, Hazelton P, Lane T, et al. A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PloS One 2012;7:e40603.
26. White JM, Mimiaga MJ, Krakower DS, Mayer KH. Evolution of Massachusetts physicians attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDs 2012;26:395-405.
27. Center for Disease Control (CDC). Interim guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have Sex with men. Morbidity Mortality Weekly Rep 2011;60:65-68.
28. Myers GM, Mayer K. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: Current considerations in light of new findings. AIDS Patient Care STDs 2011;25: 63-71.
29. Underhill K, Operario D, Skeer M, Mimiaga M, Mayer K. Packaging PrEP to prevent HIV: An integrated framework to plan for pre-exposure prophylaxis implementation in clinical practice. J Acquir Immune Defic Syndr 2010;55:8-13.
30. Golub SA, Operario D, Gorbach PM. Pre-exposure prophylaxis state of the science: Empirical analogies for research and implementation. Curr HIV/AIDS Rep 2010;7:201-209.
31. Barash EA, Golden M. Awareness and use of HIV preexposure prophylaxis among attendees of a seattle gay pride event and sexually transmitted disease clinic. AIDS Patient Care STDS 2010;24:689-691.
32. Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: Limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr 2009;50:77-83.
33. Bird ST, Bogart L.M. Conspiracy beliefs about HIV/AIDS and birth control among African Americans: Implications for the prevention of HIV, other STIs, and unintended pregnancy. J Social Issues 2005;61:109-126. (Pubitemid 40427305)
34. Halbert CH, Weathers B, Delmoor E, Mahler B, Coyne J, Thompson HS, Lee D. Racial differences in medical mistrust among men diagnosed with prostate cancer. Cancer 2009; 115:2553-2561.
35. Thompson HS, Valdimarsdottir HB, Winkel G, Jandorf L, Redd W. The group-based medical mistrust scale: Psychometric properties and association with breast cancer screening. Prev Med 2004;38:209-218. (Pubitemid 38050292)
36. Hoyt MA, Rubin LR, Nemeroff CJ, Lee J, Huebner DM, Proeschold-Bell R. HIV/AIDS-related institutional mistrust among multiethnic men who have sex with men: Effects of HIV testing and risk behaviors. Health Psychol 2012;31: 269-277.